Clinical Trials Browser

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Clinical Trials

Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer

ONCO-RET

SMART TNT

TORCH-iTNT

NLCCRIT-LARC

Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)

Involved-field Radiotherapy-TNT Combined With PD-1 Inhibitor for pMMR Locally Advanced Rectal Cancer (Neo-Field I)

CinClare-2

ShorTrip

ELECTRA

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer

Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.

MR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer

TORCH

Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal Cancer

Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and PCSK9 Inhibitor for pMMR/MSS Locally Advanced Mid-low Rectal Cancer

Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer

Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma

TransValid-A

Total Neoadjuvant Chemoradiotherapy Plus Anti-PD-1 in Subperitoneal Patients With Locally Advanced Rectal CancerPatients With Locally Advanced Rectal Cancer: A Prospective, Single Arm, Exploratory Study

Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced of Middle and Low Rectal Cancer

TRI-LARC

Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer

SHR-1701 in Combination With Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer

Dendrobium Huoshanense Suppository in Rectal Cancer

Gut Microbiome and Its Immune Modulation in Locally Advanced Rectal Cancer

Fruquintinib Plus PD-1 Antibody in pMMR / MSS Locally Advanced Rectal Cancer (LARC) With High Immune Score

Rectal Cancer, Adjuvant Chemotherapy, FOLFOX(5-fluorouracil/Leucovorin/Oxaliplatin), Total Mesorectal Excision

A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC

Neoadjuvant Short-course Radiotherapy Followed by the Combination of Immunotherapy and Chemotherapy in Locally Advanced Rectal Cancer

The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSI-H Locally Advanced Rectal Cancer

The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSS Locally Advanced Rectal Cancer

A Study of Chinese Herbal Compound Dendrobium Huoshanense Granules in NCRT for Patients With Locally Advanced Rectal Cancer

Neoadjuvant mFOLFOXIRI Chemotherapy Alone for Extramural Vascular Invasion Positive Locally Advanced Rectal Cancer

NEOTREAT

Evaluation of Efficacy, Quality of Life and Cost Effectiveness of Short-course Radiotherapy Followed by Capecitabine Plus Oxaliplatin chemotheRapy and TME for High-risk Rectal Cancer (ESCORT Trial)

UGT1A1 Combined With Pharmacokinetics of SN-38 in CPT-11-based CRT in Patients With Advanced Rectal Cancer

Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer

A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer

Trial of Celecoxib With Preoperative Chemo- Radiation for Locally Advanced Rectal Cancer

The Effect of Cancer Therapies and Exercise on Mitochondrial Energetics and Fitness